Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Aethlon Medical Inc
AEMD
Healthcare
Medical Devices
Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based...
technology. The Hemopurifier is a United States Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption application related to the treatment of life-threatening viruses that are not addressed with approved therapies.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:AEMD)
New Post
View:
Posts & Comments
Threaded Posts
(280)
•••
whytestocks
X
Post by
whytestocks
on Nov 11, 2024 1:00pm
Aethlon Medical Reaches Key Milestone with Enrollment of the
Breaking News: $AEMD Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in AustraliaAethlon Medical Reaches Key Milestone with
...more
(280)
•••
whytestocks
X
Post by
whytestocks
on Sep 19, 2024 2:45pm
Immunotherapy Clinical Trials - A New Approach to Treating C
News; $AEMD Immunotherapy Clinical Trials - A New Approach to Treating CancerVancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - September 19, 2024) - Investorideas.com , a go-to
...more
(280)
•••
whytestocks
X
Post by
whytestocks
on Aug 12, 2024 4:00pm
The Cancer Battle - How Smaller Companies Are Making Big Adv
JUST IN: $AEMD The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid TumorsVancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - August 12, 2024) -
...more
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 06, 2024 8:23am
AEMD....lots of warrants still O/S......Caveat Emptor IMHO !
AETHLON MEDICAL, INC. 8-K (sec.gov)
(37)
•••
BryceCanada
X
Post by
BryceCanada
on Jun 02, 2024 8:58pm
Excellent new YouTube analysis on AEMD
https://youtu.be/x1ZloEX6UX4?si=trNXxFtD7mFMknm6
(280)
•••
whytestocks
X
Post by
whytestocks
on May 10, 2024 2:15pm
What's Going On With Medical Therapeutic Firm Aethlon Medica
JUST IN: $AEMD What's Going On With Medical Therapeutic Firm Aethlon Medical On Friday? | BenzingaFriday,@Aethlon Medical Inc@(NASDAQ:AEMD) released results from an in vitro binding study of its
...more
(729)
•••
mercedesman
X
Post by
mercedesman
on Dec 23, 2021 9:05am
Bounce Coming ?
My spider senses are tingling again. added more in low two's maybe another pop early in the new year? As viruses continue to flourish, blood filtration is getting more
...more
(15)
•••
HDavis
X
Post by
HDavis
on Sep 21, 2021 10:27pm
AEMD - Tuesday Rundown, Wednesday Expectations
(729)
•••
mercedesman
X
Post by
mercedesman
on Sep 14, 2021 2:48pm
Starting to add again.
Especially since they are now loaded up with cash (about $ 1.67 in cash, per share o/s...low float) News of a CRO on their 40 person Covid Study soon. Maybe a few anecdotal stories to go along with
...more
(729)
•••
mercedesman
X
Comment by
mercedesman
on Jun 09, 2021 9:16am
RE:RE:RE:Reloaded
Well... I guess the market loved the two person test results from its EFS on removal of Covid-19 Exomes. Will be exiting again today with a handsome 4 bagger. MM
(37)
•••
noremac50
X
Comment by
noremac50
on May 14, 2021 8:11am
RE:RE:RE:Reloaded
Thanks!
(729)
•••
mercedesman
X
Comment by
mercedesman
on May 07, 2021 4:16pm
RE:RE:Reloaded
Hi Cam Sorry, I don't come over here often. Hemopurification is an up and coming science. Recently featured on 60 minutes. Involves removing various mediators from the blood. It'
...more
(37)
•••
noremac50
X
Comment by
noremac50
on May 04, 2021 10:43am
RE:Reloaded
alright, I started a small position. the chart itself looks tasty. What's the elevator pitch?
(729)
•••
mercedesman
X
Post by
mercedesman
on Mar 01, 2021 5:17pm
Reloaded
Low two's ...last Friday. Two conferences coming up ! Let's see how the cookie crumbles. MM
(729)
•••
mercedesman
X
Post by
mercedesman
on Dec 16, 2020 12:27pm
AEMD - the gift...
...that just keeps on giving ! Even for non-day-traders. Can you say 2 doubles and a triple ? Maybe next time a homerun? But then again, why swing for the fences when you don't have to
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Are PGM mining stocks an attractive area for your next portfolio allocation?
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities